| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |